NDAORALTABLET, EXTENDED RELEASE
Approved
Oct 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TIAMATE (diltiazem malate) is an extended-release oral tablet containing a non-dihydropyridine calcium channel blocker. It is indicated for hypertension and angina pectoris, working by inhibiting calcium influx to reduce cardiac contractility and vascular smooth muscle contraction. This product has been approved since 1996 and is now approaching loss of exclusivity.
LOE Approaching
As a mature brand approaching loss of exclusivity with moderate competitive pressure (30), this product likely operates with a lean team focused on managed decline and transition planning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
TIAMATE offers limited career growth opportunities given its approaching loss of exclusivity and minimal linked job openings (0 recorded). Working on this product provides valuable experience in mature brand management, competitive pricing, and lifecycle transition strategies—skills increasingly valuable in a generic-dominated market.
Brand ManagerProduct Manager
Worked on TIAMATE at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.